Advertisement

Clinical Rheumatology

, Volume 38, Issue 11, pp 3253–3259 | Cite as

Does symptomatic knee osteoarthritis increase the risk of all-cause mortality? Data from four international population-based longitudinal surveys of aging

  • Zidan Yang
  • Guanghua Lei
  • Xiaoxiao Li
  • Yilun Wang
  • Zikun Xie
  • Xiurui Zhang
  • Yuchen He
  • Yilin XiongEmail author
  • Tubao YangEmail author
Original Article
  • 128 Downloads

Abstract

Objective

This study aimed at examining the association between symptomatic knee osteoarthritis and all-cause mortality based on four population-based longitudinal surveys.

Method

Data were retrieved from the English Longitudinal Study of Aging (ELSA), the Survey of Health, Aging and Retirement in Europe (SHARE), the Korean Longitudinal Study of Aging (KLoSA), and the Indonesian Family Life Survey (IFLS). The association between symptomatic knee osteoarthritis and all-cause mortality over the 8- to 12-year follow-up period was assessed using Cox-proportional hazard models.

Results

In the entire sample of 59,522 participants (4823 with symptomatic knee osteoarthritis; 54,699 without symptomatic knee osteoarthritis [control group]; mean age: 61.8 years; female percentage: 55.3%), 8375 died (937 in the symptomatic knee osteoarthritis group, 7438 in the control group) during the follow-up period. Patients with symptomatic knee osteoarthritis had a higher risk of all-cause mortality than control group without adjusting for potential confounders in each survey, and the unadjusted hazard ratios (HRs) of all-cause mortality were 1.32 (95% confidence interval [CI] 1.18 to 1.47) in ELSA, 1.40 (95%CI 1.24 to 1.56) in SHARE, 1.25 (95%CI 1.06 to 1.47) in KLoSA, and 1.65 (95%CI 1.31 to 2.07) in IFLS. However, with adjustment of potential confounders, the corresponding HRs dropped to 1.07 (95%CI 0.94 to 1.20) in ELSA, 1.08 (95%CI 0.97 to 1.22) in SHARE, 0.91 (95%CI 0.77 to 1.08) in KLoSA, and 0.89 (95%CI 0.66 to 1.21) in IFLS, respectively.

Conclusions

In these four population-based longitudinal studies, no association between symptomatic knee osteoarthritis and increased risk of all-cause mortality was observed after adjusting for potential confounders.

Key Points

• This study evaluated the association between symptomatic knee OA and the risk of all-cause mortality among the participants retrieved from four large population-based longitudinal studies across the world.

• No association between symptomatic knee osteoarthritis and increased risk of all-cause mortality was observed after considering potential confounders, and our findings were consistent with the results derived from four independent longitudinal studies.

• The present study included four international population-based longitudinal studies, comprising both developed and developing areas, which allowed the findings to be interpreted under larger circumstance.

Keywords

Knee Longitudinal studies Mortality Osteoarthritis 

Notes

Acknowledgments

The authors appreciate the support of Hunan Key Laboratory of Joint Degeneration and Injury and Hunan Engineering Research Center of Osteoarthritis.

Authors’ contributions

YX and TY are joint corresponding authors. ZY, YX, and TY conceived the study. ZY, YX, and TY were responsible for conception of the study and drafted the manuscript. GL, YX, and TY were responsible for design of the study. XL, ZX, XZ, YH, contributed to preparation and data analysis. YW, TY, YX, and GL contributed to revision of the manuscript. All the authors contributed to the interpretation of the data and critically reviewed the manuscript for publication. All authors read and approved the final manuscript.

Funding information

This work was funded by the Fundamental Research Funds for the Central Universities of Central South University (2019zzts747); the National Natural Science Foundation of China (81601941, 81772413, 81702207, 81702206); the Key Research and Development Program of Hunan Province (2018SK2070, 2018SK2073); the Postdoctoral Science Foundation of Central South University (182130); the Young Investigator Grant of Xiangya Hospital, Central South University (2016Q03, 2016Q06); the Xiangya Clinical Big Data System Construction Project of Central South University (45); the Clinical Scientific Research Foundation of Xiangya Hospital, Central South University (2015L03); and the Natural Science Foundation of Hunan Province (2017JJ3491, 2017JJ3492).

Compliance with ethical standards

Ethical approval for all surveys were granted from the corresponding ethics committees: the Multicentre Research and Ethics Committee for ELSA, the Ethics Committee of the University of Mannheim for SHARE, the Seoul National University Hospital’s Institutional Review Board for KLoSA, and the ethics review boards of RAND and University of Gadjah Mada in Indonesia for IFLS. All participants provided written informed consent to participate in these surveys.

Disclosures

None.

Supplementary material

10067_2019_4672_MOESM1_ESM.pdf (145 kb)
ESM 1 (PDF 145 kb)
10067_2019_4672_MOESM2_ESM.pdf (159 kb)
ESM 2 (PDF 159 kb)

References

  1. 1.
    GBD 2015 DALYs and HALE Collaborators (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1603–1658.  https://doi.org/10.1016/S0140-6736(16)31460-X CrossRefGoogle Scholar
  2. 2.
    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1260–1344.  https://doi.org/10.1016/S0140-6736(17)32130-X CrossRefGoogle Scholar
  3. 3.
    Xing D, Xu Y, Liu Q, Ke Y, Wang B, Li Z, Lin J (2016) Osteoarthritis and all-cause mortality in worldwide populations: grading the evidence from a meta-analysis. Sci Rep 6:24393.  https://doi.org/10.1038/srep24393 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1323–1330.  https://doi.org/10.1136/annrheumdis-2013-204763 CrossRefPubMedGoogle Scholar
  5. 5.
    Kadam UT, Jordan K, Croft PR (2004) Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis 63(4):408–414CrossRefGoogle Scholar
  6. 6.
    van Dijk GM, Veenhof C, Schellevis F, Hulsmans H, Bakker JP, Arwert H, Dekker JH, Lankhorst GJ, Dekker J (2008) Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord 9:95.  https://doi.org/10.1186/1471-2474-9-95
  7. 7.
    Nielen MM, van Sijl AM, Peters MJ, Verheij RA, Schellevis FG, Nurmohamed MT (2012) Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. BMC Musculoskelet Disord 13:150.  https://doi.org/10.1186/1471-2474-13-150
  8. 8.
    Nitter A, Forseth K (2013) Mortality rate and causes of death in women with self-reported musculoskeletal pain: results from a 17-year follow-up study. Scand J Pain 4(2):86–92CrossRefGoogle Scholar
  9. 9.
    Macfarlane GJ, McBeth J, Silman AJ (2001) Widespread body pain and mortality: prospective population based study. BMJ 323(7314):662–665CrossRefGoogle Scholar
  10. 10.
    McBeth J, Symmons DP, Silman AJ, Allison T, Webb R, Brammah T, Macfarlane GJ (2009) Musculoskeletal pain is associated with a long-term increased risk of cancer and cardiovascular-related mortality. Rheumatology (Oxford) 48(1):74–77.  https://doi.org/10.1093/rheumatology/ken424 CrossRefGoogle Scholar
  11. 11.
    Torrance N, Elliott AM, Lee AJ, Smith BH (2010) Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study. Eur J Pain 14(4):380–386.  https://doi.org/10.1016/j.ejpain.2009.07.006 CrossRefPubMedGoogle Scholar
  12. 12.
    Liu R, Kwok WY, Vliet Vlieland TP, Kroon HM, Meulenbelt I, Houwing-Duistermaat JJ, Rosendaal FR, Huizinga TW, Kloppenburg M (2015) Mortality in osteoarthritis patients. Scand J Rheumatol 44(1):70–73.  https://doi.org/10.3109/03009742.2014.922213 CrossRefPubMedGoogle Scholar
  13. 13.
    Turkiewicz A, Neogi T, Bjork J, Peat G, Englund M (2016) All-cause mortality in knee and hip osteoarthritis and rheumatoid arthritis. Epidemiology 27(4):479–485.  https://doi.org/10.1097/EDE.0000000000000477 CrossRefPubMedGoogle Scholar
  14. 14.
    Cleveland RJ, Alvarez C, Schwartz TA, Losina E, Renner JB, Jordan JM, Callahan LF (2019) The impact of painful knee osteoarthritis on mortality: a communitybased cohort study with over 24 years of follow-up. Osteoarthr Cartil 27(4):593-602.  https://doi.org/10.1016/j.joca.2018.12.008
  15. 15.
    Kluzek S, Sanchez-Santos MT, Leyland KM, Judge A, Spector TD, Hart D, Cooper C, Newton J, Arden NK (2016) Painful knee but not hand osteoarthritis is an independent predictor of mortality over 23 years follow-up of a population-based cohort of middle-aged women. Ann Rheum Dis 75(10):1749–1756.  https://doi.org/10.1136/annrheumdis-2015-208056 CrossRefPubMedGoogle Scholar
  16. 16.
    Liu Q, Niu J, Huang J, Ke Y, Tang X, Wu X, Li R, Li H, Zhi X, Wang K, Zhang Y, Lin J (2015) Knee osteoarthritis and all-cause mortality: the Wuchuan osteoarthritis study. Osteoarthr Cartil 23(7):1154–1157.  https://doi.org/10.1016/j.joca.2015.03.021 CrossRefPubMedGoogle Scholar
  17. 17.
    Chan KS, Gross AL, Pezzin LE, Brandt J, Kasper JD (2015) Harmonizing measures of cognitive performance across international surveys of aging using item response theory. J Aging Health 27(8):1392–1414.  https://doi.org/10.1177/0898264315583054 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Stringhini S, Zaninotto P, Kumari M, Kivimaki M, Batty GD (2016) Lifecourse socioeconomic status and type 2 diabetes: the role of chronic inflammation in the English longitudinal study of ageing. Sci Rep 6:24780.  https://doi.org/10.1038/srep24780 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    NatCen Social Research (2018) Waves 1–8 ELSA Interviewer Data User Guide. https://www.elsa-project.ac.uk/user-guides. Accessed 26 Nov 2018
  20. 20.
    Alcser KH, Benson G, Börsch-Supan A, Brugiavini A, Christelis D, Croda E, Das M, de Luca G, Harkness J, Hesselius P, Jappelli T, Jürges H, Kalwij A, Kemperman ML, Klevmarken A, Lipps O, Paccagnella O, Padula M, Perrachi F, Rainato R, van Soest A, Swensson B, Vis C, Weber G, Weerman B (2005) The Survey of Health, Aging, and Retirement in Europe – Methodology. http://www.share-project.org/data-documentation/methodology-volumes.html. Accessed 26 Nov 2018
  21. 21.
    KLoSA Team (2007) KLoSA Wave1 User Guide. https://survey.keis.or.kr/eng/klosa/userguide/List.jsp. Accessed 26 Nov 2018
  22. 22.
    Strauss J, Witoelar F, Sikoki B, Wattie AM (2009) The fourth wave of the Indonesian family life survey (IFLS4): overview and field report. https://www.rand.org/well-being/social-and-behavioral-policy/data/FLS/IFLS/download.html. Accessed 26 Nov 2018
  23. 23.
    Tang X, Wang S, Zhan S, Niu J, Tao K, Zhang Y, Lin J (2016) The prevalence of symptomatic knee osteoarthritis in China: results from the China Health and Retirement Longitudinal Study. Arthritis Rheum 68(3):648–653.  https://doi.org/10.1002/art.39465 CrossRefGoogle Scholar
  24. 24.
    Mendy A, Park J, Vieira ER (2018) Osteoarthritis and risk of mortality in the USA: a population-based cohort study. Int J Epidemiol 47(6):1821–1829.  https://doi.org/10.1093/ije/dyy187 CrossRefPubMedGoogle Scholar
  25. 25.
    Aguayo GA, Vaillant MT, Donneau AF, Schritz A, Stranges S, Malisoux L, Chioti A, Guillaume M, Muller M, Witte DR (2018) Comparative analysis of the association between 35 frailty scores and cardiovascular events, cancer, and total mortality in an elderly general population in England: an observational study. PLoS Med 15(3):e1002543.  https://doi.org/10.1371/journal.pmed.1002543 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Kim JH, Kim JM (2017) Subjective life expectancy is a risk factor for perceived health status and mortality. Health Qual Life Outcomes 15(1):190.  https://doi.org/10.1186/s12955-017-0763-0 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Okely JA, Weiss A, Gale CR (2018) The interaction between individualism and wellbeing in predicting mortality: survey of health ageing and retirement in Europe. J Behav Med 41(1):1–11.  https://doi.org/10.1007/s10865-017-9871-x CrossRefPubMedGoogle Scholar
  28. 28.
    Sudharsanan N (2018) Population-level mortality benefits of improved blood pressure control in Indonesia: a modelling study. Int J Epidemiol.  https://doi.org/10.1093/ije/dyy232
  29. 29.
    Westreich D, Cole SR (2010) Invited commentary: positivity in practice. Am J Epidemiol 171(6):674–677; discussion 678-681.  https://doi.org/10.1093/aje/kwp436 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Hochberg MC (2008) Mortality in osteoarthritis. Clin Exp Rheumatol 26(5 Suppl 51):S120–S124PubMedGoogle Scholar
  31. 31.
    Veronese N, Cereda E, Maggi S, Luchini C, Solmi M, Smith T, Denkinger M, Hurley M, Thompson T, Manzato E, Sergi G, Stubbs B (2016) Osteoarthritis and mortality: a prospective cohort study and systematic review with meta-analysis. Semin Arthritis Rheum 46(2):160–167.  https://doi.org/10.1016/j.semarthrit.2016.04.002 CrossRefPubMedGoogle Scholar
  32. 32.
    Tsuboi M, Hasegawa Y, Matsuyama Y, Suzuki S, Suzuki K, Imagama S (2011) Do musculoskeletal degenerative diseases affect mortality and cause of death after 10 years in Japan? J Bone Miner Metab 29(2):217–223.  https://doi.org/10.1007/s00774-010-0214-z CrossRefPubMedGoogle Scholar
  33. 33.
    GBD (2016) Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1211–1259.  https://doi.org/10.1016/S0140-6736(17)32154-2 CrossRefGoogle Scholar
  34. 34.
    Ackerman IN, Pratt C, Gorelik A, Liew D (2018) Projected burden of osteoarthritis and rheumatoid arthritis in Australia: a population-level analysis. Arthritis Care Res 70(6):877–883.  https://doi.org/10.1002/acr.23414 CrossRefGoogle Scholar
  35. 35.
    Zhang Y, Niu J (2016) Editorial: shifting gears in osteoarthritis research toward symptomatic osteoarthritis. Arthritis Rheum 68(8):1797–1800.  https://doi.org/10.1002/art.39704 CrossRefGoogle Scholar
  36. 36.
    Turkiewicz A, Kiadaliri AA, Englund M (2019) Cause-specific mortality in osteoarthritis of peripheral joints. Osteoarthr Cartil 27(6):848–854.  https://doi.org/10.1016/j.joca.2019.02.793 CrossRefPubMedGoogle Scholar
  37. 37.
    World Health Organization (2018) Global status report on alcohol and health 2018. https://www.who.int/substance_abuse/publications/global_alcohol_report/en/. Accessed 25 May 2019
  38. 38.
    GBD 2016 Alcohol Collaborators (2018) Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet 392(10152):1015–1035.  https://doi.org/10.1016/S0140-6736(18)31310-2 CrossRefPubMedCentralGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2019

Authors and Affiliations

  1. 1.Department of Epidemiology and Health Statistics, Xiangya School of Public HealthCentral South UniversityChangshaChina
  2. 2.Hunan Key Laboratory of Joint Degeneration and InjuryChangshaChina
  3. 3.Department of Orthopaedics, Xiangya HospitalCentral South UniversityChangshaChina
  4. 4.National Clinical Research Center of Geriatric Disorders, Xiangya HospitalCentral South UniversityChangshaChina

Personalised recommendations